Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
Athina-Marina Metaxa, Mike Clarke
BMJ (2024), pp. e078084-e078084
Open Access | Times Cited: 24

Showing 24 citing articles:

Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Psilocybin Dispensaries and Online Health Claims in Canada
Jenna Matsukubo, Sarah Dickson, Jennifer Xiao, et al.
JAMA Network Open (2025) Vol. 8, Iss. 4, pp. e252853-e252853
Open Access | Times Cited: 1
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use
Steven Elfrink, Leigh Bergin
Frontiers in Psychology (2025) Vol. 16
Open Access
Pharmacological Monotherapy for Depressive Disorders: Current and Future, a Narrative Review
Keming Gao, Evrim Bayrak Oruc, Buket Koparal
Medicina (2025) Vol. 61, Iss. 4, pp. 558-558
Open Access
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
Noah Chisamore, Erica Kaczmarek, Zoe Doyle, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, et al.
GeroScience (2025)
Open Access
Exploring psilocybin’s role in mental health and palliative medicine: a path to improved well-being
Maria-Alejandra Umbacia, Marta León, Jose-Manuel Quintero, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Peak Experiences Matter
Danielle Leonard, Thomas R. Brooks
Journal of Humanistic Psychology (2025)
Closed Access
Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs
Nicholas C. Borgogna, Tyler Owen, Dan Petrovitch, et al.
Psychopharmacology (2025)
Open Access
Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications
Pin Gong, Jiating Wang, Hui Long, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 829-829
Open Access | Times Cited: 3
Psilocybin in pharmacotherapy of obsessive-compulsive disorder
Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 911-925
Open Access | Times Cited: 2
Autism, youth suicide, and psychedelics: A review of the 21st century evidence
Mu-Hong Chen, Tung-Ping Su, Ju‐Wei Hsu, et al.
Journal of the Chinese Medical Association (2024) Vol. 87, Iss. 10, pp. 904-911
Open Access | Times Cited: 2
Psilocybin for depression
Riccardo De Giorgi, Roger Ede
BMJ (2024), pp. q798-q798
Closed Access | Times Cited: 1
Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung
Johannes Jungwirth, Francesco Bavato, Boris B. Quednow
Der Nervenarzt (2024) Vol. 95, Iss. 9, pp. 803-810
Open Access | Times Cited: 1
Psychedelic mushroom-containing chocolate exposures: Case series
H. Gärtner, Herbert Z. Wan, Reeves E Simmons, et al.
The American Journal of Emergency Medicine (2024) Vol. 85, pp. 208-213
Closed Access | Times Cited: 1
Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis
Vikas Menon, Parthasarathy Ramamurthy, Sandesh Venu, et al.
Acta Psychiatrica Scandinavica (2024)
Closed Access | Times Cited: 1
Integrating Psychedelics into Groupwork: A Culturally Responsive Model for the Counseling Profession
Isaac Burt
Psychoactives (2024) Vol. 3, Iss. 3, pp. 357-364
Open Access
What should constitute a control condition in psychedelic drug trials?
Luana Colloca, Maurizio Fava
Nature Mental Health (2024)
Closed Access
Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol
J Pincombe, M.L. Williams, Sean P. Carruthers, et al.
(2024)
Open Access
Fenomenologia intoxicaţiei acute cu substanţe – de la date clinice la autoexperimente în mediul ştiinţific şi literar (I)
Octavian Vasiliu
Psihiatru ro (2024) Vol. 3, Iss. 78, pp. 38-38
Open Access
Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy
Andrew Gribben, T. R. JUN. BURKE, Colm Harrington, et al.
Irish Journal of Psychological Medicine (2024), pp. 1-9
Open Access
Fenomenologia intoxicaţiei acute cu substanţe – de la date clinice la autoexperimente în mediul ştiinţific şi literar (II)
Octavian Vasiliu
Psihiatru ro (2024) Vol. 4, Iss. 79, pp. 23-23
Open Access
Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials
Itsuki Terao, Wakako Kodama
Psychiatry and Clinical Neurosciences Reports (2024) Vol. 3, Iss. 4
Closed Access
Page 1

Scroll to top